📸 Highlight from #ECP2024: Eric Walk MD, FCAP, Chief Medical Officer at PathAI, presenting “Advancing Precision Medicine: PathAI and Roche Collaborate for AI-Powered Companion Diagnostics” at Roche's booth. #AI #AIHealthCare #DigitalPathology #ECP #AIPathology
PathAI
Software Development
Boston, Massachusetts 55,928 followers
Improving patient outcomes with AI-powered pathology.
About us
PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!
- Website
-
http://www.pathai.com
External link for PathAI
- Industry
- Software Development
- Company size
- 501-1,000 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2016
- Specialties
- artificial intelligence, pathology, digital pathology, oncology, immuno-oncology, auto immune disease, neurodegenerative disease, companion diagnostics, precision medicine, R&D, computational pathology, deep learning, software engineering, AI, Machine Learning, IBD, cancer research, oncology research, Drug Development, CRO , Clinical development, healthtech, and Artificial Intelligence
Locations
-
Primary
1325 Boylston St
Suite 10000
Boston, Massachusetts 02215, US
-
3495 Hacks Cross Rd
Memphis, Tennessee 38125, US
Employees at PathAI
Updates
-
Join us at Roche’s #ECP2024 booth #15 for an exciting presentation by Eric Walk MD, FCAP and MD, FCAP Chief Medical Officer at PathAI, and Michael Rivers, Lifecycle Leader for Digital Pathology at Roche Diagnostics. They will be discussing “Advancing Precision Medicine: PathAI and Roche Collaborate for AI-Powered Companion Diagnostics” from 1:10-1:30pm. Don’t miss this opportunity to learn how AI is shaping the future of diagnostics!
-
Day one at #ECP2024 is a wrap! Be sure to visit us at booth L45 tomorrow to discover how digital pathology and AI workflow solutions can benefit your anatomic pathology lab. #ECP #pathai #digitalpathology #aipathology #aiheathcare
-
Attending #ECP2024? Stop by PathAI's booth (L45) to learn how our solutions can benefit your lab. We look forward to connecting with you! #ecp2024 #ECP #anatomicpathology #digitalpathology #aipathology #heathcareai
-
🏆 We’re honored to share that PathAI is a finalist for the upcoming Biotech Week Boston Awards, in the Deal of the Year category. We look forward to connecting with our #biotech friends & peers at the awards ceremony later this month! View the Awards: https://lnkd.in/e-sU54RS #BWBawards #BostonBiotech #BostonBiotechWeek #AIPathology #digitalpathology #pathology
-
🇪🇸 We’re headed to ESMO 2024 in Barcelona, Spain on September 13 -17! Visit our booth (634a) and schedule time to meet with PathAI scientists to discuss how AI-powered #pathology can support your #oncologyresearch & #drugdevelopment with PathExplore™, IHC Explore™, PathExplore™ IOP, and more. Request a meeting, download our virtual brochures, and see our #biopharma events schedule by visiting our new events site: https://lnkd.in/eYriY_KV Gain a deeper understanding of the #tumormicroenvironment and transform routine pathology images into quantitative #histopathology insights. FEATURED AT ESMO 2024 - PathExplore™ - AI-powered panel of histopathology features that spatially characterize the tumor microenvironment. - IHC Explore™ - AI-powered biomarker quantification from #immunohistochemistry-stained slides - PathExplore™ IOP - High-resolution immuno-oncology profiling (IOP) - Real-World Data - Integrate quantitative and structured pathology data with clinico-genomic real-world data sets PathExplore™, IHC Explore™, PathExplore™ IOP are for research use only. Not for use in diagnostic procedures. #Biotech #biotechnology #digitalpathology #AI #CancerResearch #cancer #clinicaldevelopment #translationalresearch #barcelona #ESMO #ESMO24 #ESMO2024
-
Our VP of Product, Ben Glass takes the stage at WorldCDx 2024 during the workshop “From Concept to Commercialization” to discuss considerations for the integration of #digitalpathology across discovery, development and commercialization. Later today, our VP of Precision Medicine & Medical Device Development Hisani (Horne) Madison, PhD, MPH will join the Fireside Chat “Next Generation Digital Pathology Diagnostics… A Revolution in the Making” at 2:20 - 2: 50pm. View in the Program: https://lnkd.in/gzECpUa4 Topics include: 1) Evolution of quantitative #IHC including QCS 2) Incorporating Digital Pathology including #AI in the discovery phase 3) Navigating the DP landscape 4) Impact of Digital #Pathology on Patient Care Connect with us and attend the presentation at the 14th World Clinical Biomarkers & Companion Diagnostics Summit: https://lnkd.in/eTVsBzUN #WorldCDX #WorldCDX2024
-
🔎 Experience AI-powered #pathology: See for yourself by accessing our new #AI demo platform: https://lnkd.in/ekvNMYru Dive deeper into #histopathology with our translational research demo platform for oncology, liver disease, and IBD research solutions. Our self-serve platform lets you experience the use of AI for analyzing routine pathology images, providing comprehensive, quantitative insights into the tumor and inflammatory microenvironments. Demo Focus Areas: #Oncology - PathExplore™: Spatially-resolved, #singlecell analysis from H&E - PathExplore™ IOP: Immune #Phenotyping & TIL Characterization - IHC Explore™: AI-powered #biomarker quantification #IBD, #Liver & #MASH - IBD Explore™: Spatial, single cell-resolution of the inflammatory microenvironment - Liver Explore™: Characterize liver tissue #biopsy microarchitecture 🔍 Enhance what you see and reveal what you cannot - Analyze routine pathology images such as H&E and IHC with single-cell, spatial resolution - Extract standardized and structured histopathology features to enable pathology research at scale - Visualize disease heterogeneity, cell populations, and tissue architectures with high-resolution AI-powered overlays PathExplore™ , PathExplore™ IOP, IHC Explore™, Liver Explore™, and IBD Explore™ are for research use only. Not for use in diagnostic procedures. #Biotech #AIPathology #WorldCDX #ESMO24 #Biotechnology #digitalpathology #cancerresearch #PrecisionMedicine
-
PathAI, a global leader in #digitalpathology, announced that GoldPath Labs, an independent pathology service provider based in Duarte, California, has adopted the AISight® Image Management System (IMS). GoldPath selected AISight after an extensive evaluation of various image management systems, recognizing it as the optimal solution to streamline workflows, enhance case management, and support a broad range of use cases. "As we continue to see a growing need for high-quality pathology services, integrating digital pathology is essential to maintaining our competitive edge and ensuring the best patient outcomes. AISight stood out for its robust capabilities, offering the versatility we need to manage our caseload effectively and improve efficiencies throughout our processes," said Gerardo De La O, CEO and Co-Founder of GoldPath. "The selection of PathAI's AISight Image Management System by a forward-thinking independent laboratory like GoldPath highlights the significant impact our technology can have on #pathology operations. Their adoption of AISight demonstrates how our solution can enhance laboratory efficiency in the rapidly evolving field of digital pathology," said Andrew Beck, MD, PhD, co-founder and CEO of PathAI. "We are excited to support GoldPath as they set new standards for pathology services." 🔗 Discover how PathAI’s #digitaldiagnostics solutions can transform pathology labs in our latest #pressrelease: https://lnkd.in/eviPiwHv #PathAI #AISight #DigitalPathology #AI #biotech #partnership #biotechnology #AIPathology AISight® is for research use only. Not for use in diagnostic procedures.
-
🔬 Transform #Immunohistochemistry (#IHC) slide images into precise, data-driven insights for next-gen #biomarker development. Demo the new #IHCExplore™ platform: https://lnkd.in/ekvNMYru Characterize IHC stains and biomarker #expression with #singlecell accuracy and spatial context. - Speed up AI-enabled biomarker development for innovative IHC assays. - Scale rapidly for continuous biomarker quantification. - Obtain deep, quantitative data on cell types, stain intensity, and completeness. - Identify spatial patterns and expression heterogeneity beyond conventional scoring. - Discover unique sub-populations that advance biomarker discovery and standardization. Learn more about IHC Explore™: https://lnkd.in/eXF2scEV Enhance #cancer #drugdevelopment and #clinicalresearch with AI-powered insights from IHC slides. Try the platform today! IHC Explore™ is for research use only. Not for use in diagnostic procedures. #Pathology #biotech #AI #MachineLearning #Healthtech #AIPathology #ClinicalDevelopment #DrugDevelopment #WorldCDX2024 #WorldCDX24 #WorldCDx #biotechnology #ArtificialIntelligence #IHC #Histochemistry #biomarkers #drugdiscovery